Fabian Frechen

Fabian Frechen

Auto-generated profile, based on publicly available information

Fabian Frechen

Institute of Innate Immunity, Molecular Physiology and Biophysical Imaging, University of Bonn, Bonn, Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
JBJulian Brands
Julian Brands
SBSergi Bravo
Sergi Bravo
LJLars Jürgenliemke
Lars Jürgenliemke
LGLukas Grätz
Lukas Grätz
HSHannes Schihada
Hannes Schihada
EKEvi Kostenis
Evi Kostenis
A long-held tenet in inositol-lipid signaling is that cleavage of membrane phosphoinositides by phospholipase Cβ (PLCβ) isozymes to increase cytosolic Ca2+ in living cells is exclusive to Gq- and Gi-sensitive G protein-coupled receptors (GPCRs). Here we extend this central tenet and show that Gs-GPCRs also partake in inositol-lipid signaling and thereby increase cytosolic Ca2+. By combining CRISPR/Cas9 genome editing to delete Gαs, the adenylyl cyclase isoforms 3 and 6, or the PLCβ1-4 isozymes, with pharmacological and genetic inhibition of Gq and G11, we pin down Gs-derived Gβγ as driver of a PLCβ2/3-mediated cytosolic Ca2+ release module. This module does not require but crosstalks with Gαs-dependent cAMP, demands Gαq to release PLCβ3 autoinhibition, but becomes Gq-independent with mutational disruption of the PLCβ3 autoinhibited state. Our findings uncover the key steps of a previously unappreciated mechanism utilized by mammalian cells to finetune their calcium signaling regulation through Gs-GPCRs.

30 August 2023 in Journal of Molecular Biology
Verified
Journal Article
Closed access
QXQianzhao Xu
Qianzhao Xu
AVArend Vogt
Arend Vogt
FFFabian Frechen
Fabian Frechen
CYChengwei Yi
Chengwei Yi
MKMelike Küçükerden
Melike Küçükerden
AMAndreas Möglich
Andreas Möglich

20 August 2025 in The EMBO Journal
Verified
Journal Article
Open access
KSKatharina Sieckmann
Katharina Sieckmann
NWNora Winnerling
Nora Winnerling
DRDalila Juliana Silva Ribeiro
Dalila Juliana Silva Ribeiro
SYSeniz Yüksel
Seniz Yüksel
RKRonja Kardinal
Ronja Kardinal
DWDagmar Wachten
Dagmar Wachten
The primary cilium plays a crucial role in regulating whole-body energy metabolism, as reflected in Bardet-Biedl syndrome (BBS), where ciliary dysfunction leads to obesity due to hyperphagia and white adipose tissue (WAT) remodeling. Regulation of the fate and differentiation of adipocyte precursor cells (APCs) is essential for maintaining WAT homeostasis during obesity. Using Bbs8 −/− mice that recapitulate the BBS patient phenotype, we demonstrate that primary cilia dysfunction reduces the stem-cell-like P1 APC subpopulation by inducing a phenotypic switch to a fibrogenic progenitor state. This switch is characterized by extracellular matrix (ECM) remodeling and upregulation of the fibrosis marker CD9, even before the onset of obesity. Single-cell RNA sequencing reveals a direct transition of P1 APCs into fibrogenic progenitors, bypassing the committed P2 progenitor state. Ectopic ciliary Hedgehog signaling upon loss of BBS8 appears as a central driver of the molecular changes in Bbs8 −/− APCs, altering their differentiation into adipocytes and promoting their lipid uptake. These findings unravel a novel role for primary cilia in governing APC fate by determining the balance between adipogenesis and fibrogenesis, and suggest potential therapeutic targets for obesity.

25 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SEStefan Ebner
Stefan Ebner
KPKshiti Meera Phulphagar
Kshiti Meera Phulphagar
YAYubell Alvarez
Yubell Alvarez
LJLars Jürgenliemke
Lars Jürgenliemke
FFFabian Frechen
Fabian Frechen
FMFelix Meissner
Felix Meissner
Organellar perturbations are linked to NLRP3 inflammasome activation, however, it remains unclear whether unrelated agonists converge on a common upstream pathway. Here, we traced intracellular organelle and protein movements by differential ultracentrifugation combined with mass spectrometry-based proteomics. We show that NLRP3 activators uniformly disrupt the endocytic Adaptor Protein 2 (AP2) complex, whereas other subcellular rearrangements are stimulus-specific. We discovered Dynasore as a K⁺-efflux–independent NLRP3 activator that engages this signaling node irrespective of endocytosis inhibition. Pharmacological and genetic perturbation of AP2 renders cells unresponsive to extracellular cues, blunting GPCR signaling, cAMP production, and chemotaxis, thereby enforcing a ’frozen’ signaling state that propagates NLRP3 inflammasome activation. Collectively, our study reveals a common surveillance checkpoint linking impaired plasma membrane signaling to the execution of inflammation and cell death. Graphical